Norway: Introduction and subsequent termination of export ban on six pharmaceutical products following the outbreak of COVID-19

Announcement

11 May 2020

In May 2020, the Norwegian authorities introduced an export ban on six pharmaceutical products due to concerns of domestic shortages following the COVID-19 pandemic. In June 2020, the export ban was terminated.

Source

Number of interventions

1 certainly harmful

0 likely harmful

0 liberalising

List of interventions

Implementation date

11 May 2020

Revocation date:

14 Jun 2020

Updated: 11 May 2020

Export ban

On 11 May 2020, the Norwegian Medicines Agency introduced an export ban on salmeterol, olodaterol, olodaterol and tiotropium bromide, formoterol and budesonide, formoterol and beclom...

Related State Acts

15 Jun 2020

Norway: Introduction of export notification requirement on several pharmaceutical goods (COVID-19)

21 Apr 2020

Norway: Introduction of export notification requirement on medications for treating obstructive pulmonary diseases following the COVID-19 outbreak

Threads

See all

This state act is not part of any Thread yet.